Meningococcal Vaccines Market Research Report by Type, by Category, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Meningococcal Vaccines Market Research Report by Type, by Category, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • August 2020 •
  • 148 pages •
  • Report ID: 5912936 •
  • Format: PDF
Meningococcal Vaccines Market Research Report by Type (Combination Vaccines, Conjugate Vaccines, Men B Vaccines, and Polysaccharide Vaccines), by Category (Intramuscular and Subcutaneous), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global Meningococcal Vaccines Market is expected to grow from USD 4,190.35 Million in 2019 to USD 8,033.15 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.45%.

Market Segmentation & Coverage:
This research report categorizes the Meningococcal Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Conjugate Vaccines is projected to witness the highest growth during the forecast period"

Based on Type, the Meningococcal Vaccines Market studied across Combination Vaccines, Conjugate Vaccines, Men B Vaccines, and Polysaccharide Vaccines. The Combination Vaccines further studied across MenHibrix and Menitorix. The Conjugate Vaccines further studied across Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, and NmVac4-DT. The Men B Vaccines further studied across Bexsero and Trumenba. The Polysaccharide Vaccines further studied across Mencevax, Menomune, and NmVac4. The Men B Vaccines commanded the largest size in the Meningococcal Vaccines Market in 2019. On the other hand, the Conjugate Vaccines is expected to grow at the fastest CAGR during the forecast period.

"The Intramuscular is projected to witness the highest growth during the forecast period"

Based on Category, the Meningococcal Vaccines Market studied across Intramuscular and Subcutaneous. The Intramuscular commanded the largest size in the Meningococcal Vaccines Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Pediatric Clinic is projected to witness the highest growth during the forecast period"

Based on End User, the Meningococcal Vaccines Market studied across Hospital Pharmacies, Pediatric Clinic, and Retail Pharmacies. The Hospital Pharmacies commanded the largest size in the Meningococcal Vaccines Market in 2019. On the other hand, the Pediatric Clinic is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Meningococcal Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Meningococcal Vaccines Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Meningococcal Vaccines Market including Bio-Manguinhos, Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline PLC, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd., and Walvax Biotechnology Co., Ltd..

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Meningococcal Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Meningococcal Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Meningococcal Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Meningococcal Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Meningococcal Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Meningococcal Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Meningococcal Vaccines Market?